Back to Search Start Over

Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery.

Authors :
Cheleski J
Rocha JR
Pinheiro MP
Wiggers HJ
da Silva AB
Nonato MC
Montanari CA
Source :
European journal of medicinal chemistry [Eur J Med Chem] 2010 Dec; Vol. 45 (12), pp. 5899-909. Date of Electronic Publication: 2010 Oct 07.
Publication Year :
2010

Abstract

The enzyme dihydroorotate dehydrogenase (DHODH) has been suggested as a promising target for the design of trypanocidal agents. We report here the discovery of novel inhibitors of Trypanosoma cruzi DHODH identified by a combination of virtual screening and ITC methods. Monitoring of the enzymatic reaction in the presence of selected ligands together with structural information obtained from X-ray crystallography analysis have allowed the identification and validation of a novel site of interaction (S2 site). This has provided important structural insights for the rational design of T. cruzi and Leishmania major DHODH inhibitors. The most potent compound (1) in the investigated series inhibits TcDHODH enzyme with Kiapp value of 19.28 μM and possesses a ligand efficiency of 0.54 kcal mol(-1) per non-H atom. The compounds described in this work are promising hits for further development.<br /> (Copyright © 2010 Elsevier Masson SAS. All rights reserved.)

Details

Language :
English
ISSN :
1768-3254
Volume :
45
Issue :
12
Database :
MEDLINE
Journal :
European journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
20965617
Full Text :
https://doi.org/10.1016/j.ejmech.2010.09.055